The need for greater opioid pharmacovigilance in COPD

Abstract

Nicholas T Vozoris1–3 1Division of Respirology, Department of Medicine, St Michael’s Hospital, Toronto, ON, Canada; 2Keenan Research Centre in the Li Ka Shing Knowledge Institute, St Michael’s Hospital, Toronto, ON, Canada; 3Department of Medicine, University of Toronto, Toronto, ON, Canada I read with interest the article by Ahmadi et al1 that described the use of prescription opioid drugs among Swedes with advanced COPD. The authors are to be commended for their research work on this important clinical topic. I would like to bring to the attention of your readers several points though. Read the original article by Ahmadi et al

Keywords

• COPD
• opioids
• pharmacovigilence
• pharmacoepidemiology